Press release

Datesort ascending Press release
10/12/2018 Inventiva invited to present at the 37th Annual J.P. Morgan Healthcare Conference
07/11/2018 Inventiva Announces Poster Presentation on Its YAP/TEAD Inhibitor Program at the EORTC-NCI-AACR Symposium in Dublin
30/10/2018 Inventiva invited to present at Stifel 2018 Healthcare Conference in New York and at Jefferies 2018 London Healthcare Conference
17/10/2018 Inventiva announces two appointments to its management team ahead of future key development milestones
15/10/2018 Inventiva Announces Last Visit by Last Patient in its Phase IIb SSc Trial and Second Positive DSMB Review in its Phase IIb NASH Trial with Lanifibranor
12/10/2018 Inventiva to Participate in the “ROTH Battle of the NASH Thrones Investor Conference”
10/10/2018 Inventiva Announces Two Poster Presentations at the American College of Rheumatology Conference
24/09/2018 Inventiva launches an independent working group to help increase NASH awareness and establish best practices for its treatment
30/08/2018 Inventiva advances in the development of lanifibranor with the achievement of three key milestones
29/08/2018 Inventiva to Present at the H.C. Wainwright 20th Annual Global Investment Conference
22/08/2018 Inventiva announces that it has been informed of the modification of the call option agreement concluded by BVF Partners L.P.
13/08/2018 Inventiva’s lanifibranor found to have good safety profile following first assessment of carcinogenicity studies’ results
01/08/2018 Inventiva to Present the Latest Findings in its RORγ program at the 256th National Meeting of the American Chemical Society
26/07/2018 Inventiva Announces Poster Presentation on a Promising Biomarker for MPS VI at the 15th International Symposium on MPS and Related Diseases
10/07/2018 Inventiva Announces Positive DSMB Reviews in both NASH and Systemic Sclerosis Phase IIb Trials with Lanifibranor
20/06/2018 FDA Approval of an Investigator Initiated IND Application to Conduct Phase II Study of Lanifibranor in Type 2 Diabetic Patients with Non-Alcoholic Fatty Liver Disease
11/06/2018 Inventiva to Present at the 2018 JMP Securities Life Sciences Conference
30/05/2018 Inventiva to Present at the Jefferies 2018 Global Healthcare Conference
29/05/2018 Résultat des votes de l’Assemblée Générale du 28 mai 2018 (french only)
28/05/2018 Dr Lucy Lu is appointed to the Inventiva Board of Directors